| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director | Stock Options (right to buy) | 75,000 | 09 Dec 2024 | Direct | ||
| MIRA PHARMACEUTICALS, INC. | Director | Nonqualified Stock Option (right to buy) | 25,000 | 25 Mar 2024 | Direct | ||
| Telomir Pharmaceuticals, Inc. | Director | Incentive Stock Options (right to buy) | 25,000 | 27 Aug 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MIRA | MIRA PHARMACEUTICALS, INC. | 09 Dec 2024 | 1 | $0 | 4 | Director | 10 Dec 2024, 17:15 |
| TELO | Telomir Pharmaceuticals, Inc. | 27 Aug 2024 | 1 | $0 | 4 | Director | 29 Aug 2024, 16:05 |
| TELO | Telomir Pharmaceuticals, Inc. | 08 Aug 2024 | 0 | $0 | 3 | Director | 15 Aug 2024, 11:17 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 25 Mar 2024 | 1 | $0 | 4 | Director | 27 Mar 2024, 17:53 |
| MIRA | MIRA PHARMACEUTICALS, INC. | 13 Mar 2024 | 0 | $0 | 3 | Director | 22 Mar 2024, 16:15 |